Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Device Gammatile Therapy 12pk (CDM PX-2897591) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 17, 2026 , from http://ppman.hank.ai/transparency/procedure/PX-2897591/by-state?code_type=CDM
“Device Gammatile Therapy 12pk (CDM PX-2897591) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/PX-2897591/by-state?code_type=CDM. Accessed
October 17, 2026 .
“Device Gammatile Therapy 12pk (CDM PX-2897591) by State,” HANK Price Transparency ,
accessed October 17, 2026 ,
http://ppman.hank.ai/transparency/procedure/PX-2897591/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
PX-2897591 — Device Gammatile Therapy 12pk
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$166,281
National median
$149,722 – $184,712
IQR (p25 – p75)
9
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for PX-2897591 (CDM), with interquartile range
State Median p25 p75
NC $166,281 $149,722 $184,712